Journal article
Efficacy of desloratadine in intermittent allergic rhinitis: a GA2LEN study
Abstract
BACKGROUND: The Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines proposed a classification for allergic rhinitis based on the duration of symptoms (intermittent, persistent) rather than on the time of allergen exposure (seasonal, perennial). There is no placebo-controlled, randomized clinical trial on intermittent allergic rhinitis (IAR) to date. Desloratadine (DL) is recommended for the first-line treatment of seasonal and …
Authors
Bousquet J; Bachert C; Canonica GW; Mullol J; Van Cauwenberge P; Jensen CB; Fokkens WJ; Ring J; Keith P; Lorber R
Journal
Allergy, Vol. 64, No. 10, pp. 1516–1523
Publisher
Wiley
Publication Date
October 2009
DOI
10.1111/j.1398-9995.2009.02115.x
ISSN
0001-5148